| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Oncology and Molecular Endocrinology Research Center, and the 4Ophthalmology Research Unit, University Hospital Center of Laval (CHUL) Research Center, Québec, Canada; and the 3Laboratory of Experimental Organogenesis, Saint-Sacrement Hospital, University Affiliated Hospital Center (CHA), Laval University, Québec, Canada.
PURPOSE. Primary cultured epithelial cells are widely used for the production of tissue-engineered substitutes and are gaining popularity as a model for gene expression studies. However, as such cells are passaged in culture, they often lose their ability to proliferate by progressing toward terminal cell differentiation, a process likely to be determined by altered expression of transcription factors that have functions critical for cell adhesion and differentiation. This study was designed to determine whether the variable life span of primary cultured human corneal epithelial cells (HCECs) might be the consequence of varying expression levels of the well-known transcription factors Sp1 and Sp3 (Sp1/Sp3).
METHODS. HCECs were obtained from donor eyes and cultured on irradiated Swiss-3T3. Sp1/Sp3 expression was monitored by Western blot and electrophoretic mobility shift assay (EMSA). The Sp1/Sp3 regulatory influence was evaluated by transfection of HCECs with a recombinant plasmid bearing the Sp1/Sp3-dependent poly(ADP-ribose) polymerase (rPARP) promoter fused to the CAT reporter gene. HCECs that expressed various levels of Sp1/Sp3 were also used for the production of corneal substitutes.
RESULTS. Expression of Sp1/Sp3 was dramatically inconsistent between HCECs isolated from the eyes of different donors. Both factors were highly expressed during one passage and then totally disappeared as cells terminally differentiated. Proper stratification of HCECs on reconstructed tissue substitutes could be obtained only with cells that also had a delayed peak of Sp1/Sp3 expression when cultured in vitro.
CONCLUSIONS. Expression of Sp1/Sp3 may represent a good predictor for selecting HCECs that are most likely to proliferate, stratify, and differentiate properly when used for the production of reconstructed corneal substitutes.
This article has been cited by other articles:
|
|
 |
|
  P. Carrier, A. Deschambeault, M. Talbot, C. J. Giasson, F. A. Auger, S. L. Guerin, and L. Germain Characterization of Wound Reepithelialization Using a New Human Tissue-Engineered Corneal Wound Healing Model Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1376 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gaudreault, F. Vigneault, S. Leclerc, and S. L. Guerin Laminin Reduces Expression of the Human {alpha}6 Integrin Subunit Gene by Altering the Level of the Transcription Factors Sp1 and Sp3 Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3490 - 3505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V A Shanmuganathan, A P Rotchford, A B Tullo, A Joseph, I Zambrano, and H S Dua Epithelial proliferative potential of organ cultured corneoscleral rims; implications for allo-limbal transplantation and eye banking Br. J. Ophthalmol., January 1, 2006; 90(1): 55 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lambiase, D. Merlo, C. Mollinari, P. Bonini, A. M. Rinaldi, M. D Amato, A. Micera, M. Coassin, P. Rama, S. Bonini, et al. Molecular basis for keratoconus: Lack of TrkA expression and its transcriptional repression by Sp3 PNAS, November 15, 2005; 102(46): 16795 - 16800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-E. Gingras, K. Larouche, N. Larouche, S. Leclerc, C. Salesse, and S. L. Guerin Regulation of the Integrin Subunit {alpha}5 Gene Promoter by the Transcription Factors Sp1/Sp3 Is Influenced by the Cell Density in Rabbit Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3742 - 3755. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
